3 months Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals Zacks
Alimera (ALIM) is set to be acquired by ANI Pharmaceuticals for approximately $381 million in upfront consideration. The transaction is expected to close in the third quarter of 2024.